Paul N. Clark, Director at BIOLASE, INC (BIOL), bought 134,579 shares at $0.78 ($101K) on 2015-11-09, disclosed to the SEC on 2015-11-12.
Open-market purchase of $101k BIOL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 11,646 | $9K | 8.6% |
| 2 | $0.76 | 7,000 | $5K | 5.2% |
| 3 | $0.77 | 2,800 | $2K | 2.1% |
| 4 | $0.78 | 2,923 | $2K | 2.2% |
| 5 | $0.79 | 10,210 | $8K | 8.0% |
| 6 | $0.73 | 4,300 |
| $3K |
| 3.1% |
| 7 | $0.74 | 39,699 | $29K | 29.0% |
| 8 | $0.75 | 23,501 | $18K | 17.4% |
| 9 | $0.76 | 32,500 | $25K | 24.4% |
| Total | $0.75 avg | 134,579 | $101K | 100% |
| Filing → |
| A | SELL | 2017-05-30 | $457K | — | Filing → |
| A | SELL | 2016-11-18 | $426K | — | Filing → |
| A | SELL | 2015-03-05 | $1.6M | — | Filing → |